An open label study to assess the efficacy of losartan/HCTZ [hydrochlorothiazide] combination therapy in patients with essential hypertension who were inadequately controlled on current antihypertensive monotherapy

Trial Profile

An open label study to assess the efficacy of losartan/HCTZ [hydrochlorothiazide] combination therapy in patients with essential hypertension who were inadequately controlled on current antihypertensive monotherapy

Completed
Phase of Trial: Phase III

Latest Information Update: 12 May 2017

At a glance

  • Drugs Losartan/hydrochlorothiazide (Primary)
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Acronyms HEAALTH
  • Sponsors Merck Sharp & Dohme
  • Most Recent Events

    • 25 Jul 2007 The expected completion date for this trial is now 1 Apr 2007.
    • 12 Feb 2007 Status change
    • 28 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top